Discussion on the Antipruritic Mechanism of Qiwei Antipruritic Based on Network Pharmacology and Molecular Docking Technology

References

• Elke W, Szepietowski Jacek C, Dalgard Florence J, et al. European S2k guideline on chronic pruritus. Acta Derm Venereol. 2019;99:469–506.
   PubMed Web of Science ®Google Scholar
• Robert S, Davis dawn M, Cohen David E, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–349. doi:10.1016/j.jaad.2014.03.030
   PubMed Web of Science ®Google Scholar
• Simons FER. Advances in H 1 -Antihistamines. N Engl J Med. 2004;351(21):2203–2217. doi:10.1056/NEJMra033121
   PubMed Web of Science ®Google Scholar
• K CM, Maurer M, R SFE, et al. Risk of first-generation H 1 -antihistamines: a GA 2 LEN position paper. Allergy. 2010;65(4):459–466. doi:10.1111/j.1398-9995.2009.02325.x
   PubMed Web of Science ®Google Scholar
• Simon FER, Simons KJ. H1 antihistamines: current status and future directions. World Allergy Organ J. 2008;1(9):145–155. doi:10.1186/1939-4551-1-9-145
   PubMedGoogle Scholar
• Hengge Ulrich R, Thomas R, Schwartz Robert A, et al. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1–15; quiz 16–8. doi:10.1016/j.jaad.2005.01.010
   Web of Science ®Google Scholar
• Hopkins AL. Network pharmacology. Nat Biotechnol. 2007;25(10):1110–1111. doi:10.1038/nbt1007-1110
   PubMed Web of Science ®Google Scholar
• Wu Z, Yang T, Ma H. Molecular mechanism of modified Huanglian Wendan decoction in the treatment of polycystic ovary syndrome. Medicine (Baltimore). 2023;102(15):e33212. doi:10.1097/MD.0000000000033212
   PubMed Web of Science ®Google Scholar
• Yang J, Tian S, Zhao J, et al. Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning. Pharmacol Res. 2020;159:105034. doi:10.1016/j.phrs.2020.105034
   PubMed Web of Science ®Google Scholar
• A LC, Lombardo F, W DB, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3–26.
   PubMed Web of Science ®Google Scholar
• Marilyn S, Irina D, Justin A, et al. GeneCards Version 3: the human gene integrator. Database (Oxford). 2010;2010:baq020.
   PubMedGoogle Scholar
• Taila H, Tuğçe B B, Rojas Samantha K, et al. The unsolved rare genetic disease atlas? An analysis of the unexplained phenotypic descriptions in OMIM®. Am J Med Genet C Semin Med Genet. 2018;178:458–463.
   PubMed Web of Science ®Google Scholar
• Dimmer Emily C, Huntley Rachael P, Yasmin A-F, et al. The UniProt-GO annotation database in 2011. Nucleic Acids Res. 2012;40(D1):D565–70. doi:10.1093/nar/gkr1048
   PubMed Web of Science ®Google Scholar
• Jeong H, P MS, L BA, et al. Lethality and centrality in protein networks. Nature. 2001;411(6833):41–42. doi:10.1038/35075138
   PubMed Web of Science ®Google Scholar
• Tang Y, Min L, Jianxin W, et al. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 2015;127:67–72. doi:10.1016/j.biosystems.2014.11.005
   PubMed Web of Science ®Google Scholar
• Guangchuang Y, Li-Gen W, Yanyan H, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284–7.
   PubMed Web of Science ®Google Scholar
• Wencke W, Fátima S, Mercedes R. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31(17):2912–4.
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–461. doi:10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Jere SW, Houreld NN, Abrahamse H. Photobiomodulation at 660nm stimulates proliferation and migration of diabetic wounded cells via the expression of epidermal growth factor and the JAK/STAT pathway. J Photochem Photobiol B. 2018;179:74–83. doi:10.1016/j.jphotobiol.2017.12.026
   PubMed Web of Science ®Google Scholar
• Clabbers JMK, Boers–Doets CB, Gelderblom H, et al. Xerosis and pruritus as major EGFRI-associated adverse events. Support Care Cancer. 2016;24(2):513–521. doi:10.1007/s00520-015-2781-y
   PubMed Web of Science ®Google Scholar
• Eilers ER, Gandhi M, Patel JD, et al. Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy. J Natl Cancer Inst. 2010;102(1):47–53. doi:10.1093/jnci/djp439
   PubMedGoogle Scholar
• White MJ, Tacconelli A, Chen JS, et al. Epiregulin (EREG) and human V-ATPase (TCIRG1): genetic variation, ethnicity and pulmonary tuberculosis susceptibility in Guinea-Bissau and The Gambia. Genes Immun. 2014;15(6):370–377. doi:10.1038/gene.2014.28
   PubMed Web of Science ®Google Scholar
• Francesca M, Valentina M, Giampiero G, et al. Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. Am J Pathol. 2003;163(1):303–312. doi:10.1016/S0002-9440(10)63654-1
   PubMed Web of Science ®Google Scholar